Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance and Beta Cell Function of Metformin Treated Women With Polycystic Ovary Syndrome

Trial Profile

Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance and Beta Cell Function of Metformin Treated Women With Polycystic Ovary Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 May 2016

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top